Literature DB >> 27474394

Shipping Drug Resistance: Extracellular Vesicles in Ovarian Cancer.

Elke Pogge von Strandmann1, Rolf Müller2.   

Abstract

Ovarian cancer is a deadly disease, largely because of relapse and chemotherapy resistance. Common genetic mechanisms causing drug resistance have not been identified. A recent study unravels a novel and unexpected pathway involving the transfer of microvesicle-encapsulated miRNA from omental adipocytes and fibroblasts, to cancer cells.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27474394     DOI： 10.1016/j.molmed.2016.07.006

Source DB:  PubMed          Journal:  Trends Mol Med        ISSN： 1471-4914            Impact factor:   11.951


  6 in total

Review 1.  The Unique Molecular and Cellular Microenvironment of Ovarian Cancer.

Authors:  Thomas Worzfeld; Elke Pogge von Strandmann; Magdalena Huber; Till Adhikary; Uwe Wagner; Silke Reinartz; Rolf Müller
Journal:  Front Oncol       Date:  2017-02-22       Impact factor: 6.244

2.  DDP-resistant ovarian cancer cells-derived exosomal microRNA-30a-5p reduces the resistance of ovarian cancer cells to DDP.

Authors:  Ronghua Liu; Yucan Zhang; Peiwen Sun; Changxiu Wang
Journal:  Open Biol       Date:  2020-04-29       Impact factor: 6.411

3.  Phosphoproteomics identify arachidonic-acid-regulated signal transduction pathways modulating macrophage functions with implications for ovarian cancer.

Authors:  Raimund Dietze; Mohamad K Hammoud; María Gómez-Serrano; Annika Unger; Tim Bieringer; Florian Finkernagel; Anna M Sokol; Andrea Nist; Thorsten Stiewe; Silke Reinartz; Viviane Ponath; Christian Preußer; Elke Pogge von Strandmann; Sabine Müller-Brüsselbach; Johannes Graumann; Rolf Müller
Journal:  Theranostics       Date:  2021-01-01       Impact factor: 11.556

Review 4.  Neoadjuvant treatment in ovarian cancer: New perspectives, new challenges.

Authors:  Adamantia Nikolaidi; Elena Fountzilas; Florentia Fostira; Amanda Psyrri; Helen Gogas; Christos Papadimitriou
Journal:  Front Oncol       Date:  2022-07-26       Impact factor: 5.738

Review 5.  Regulation of Ovarian Cancer Prognosis by Immune Cells in the Tumor Microenvironment.

Authors:  Maureen L Drakes; Patrick J Stiff
Journal:  Cancers (Basel)       Date:  2018-09-01       Impact factor: 6.639

6.  Cancer-associated fibroblast-derived exosomal microRNA-24-3p enhances colon cancer cell resistance to MTX by down-regulating CDX2/HEPH axis.

Authors:  Hong-Wei Zhang; Yi Shi; Ji-Bin Liu; Hui-Min Wang; Pei-Yao Wang; Zhi-Jun Wu; Liu Li; Li-Peng Gu; Ping-Sheng Cao; Gao-Ren Wang; Yu-Shui Ma; Da Fu
Journal:  J Cell Mol Med       Date:  2021-02-23       Impact factor: 5.310
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.